Abstract: The present invention relates to method of inhibition of cellular endocytosis by treating the cells with compound of formula-1 Diphenylthio urea and Diphenylurea derivatives. Said invention also discloses method of treatment of infectious diseases, neurological disease, cancer, kidney disease in a subject in need thereof by administering therapeutically effective concentration of compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives which are effective inhibitors of cellular endocytosis. Said invention also discloses compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives and pharmaceutical composition comprising compounds of Formula-1, Diphenylthio urea and Diphenylurea derivatives along with suitable excipients.

Abstract: Various embodiments of the present invention utilize systems, methods, and computer program products that perform predictive data analysis operations by determining, using a diagnostic classification machine learning model, and based at least in part on a plurality of diagnostic feature values for the monitored individual, a selected diagnostic profile classification of a plurality of defined diagnostic profile classifications, wherein each defined diagnostic profile classification is associated with an inferred endometriosis prediction and an inferred endometriosis diagnosis history prediction; and in response to determining that the inferred endometriosis prediction for the selected diagnostic profile classification is an affirmative inferred endometriosis prediction: determining, using a recommendation classification machine learning model, and based at least in part on a plurality of recommendation feature values, a selected recommendation profile classification of a plurality of defined recommendation pr

Abstract: A method, system, and non-transitory computer-readable storage medium for temporal information synchronization of imaging devices are disclosed. The method comprises capturing media using an imaging device, generating a sequence identifier for each of the media, generating a timestamp for each of the media, determining that at least one of the media includes an unknown time tag, receiving an input including temporal information, determining a time offset between each timestamp and the temporal information, and updating the timestamp for each of the media that includes an unknown time tag using the time offset to provide an updated timestamp.

Abstract: There is a need for improving data security in enrollment management systems. This need can be addressed by, for example, solutions for determining an enrollment recommendation for a primary member profile based on preconfigured enrollment modeling data. In one example, a method includes retrieving enrollment modeling data for a group of member profiles, determining a plurality of related member profiles for the primary member profile from the group of member profiles, determining a cross-member enrollment prediction for the primary member profile by comparing enrollment modeling data of the primary member profile and enrollment modeling data of each related member profile, determining a member-specific enrollment recommendation by comparing enrollment modeling data of the primary member profile and enrollment coverage criteria for each enrollment plan, and determining the enrollment recommendation based on the cross-member enrollment prediction and the member-specific enrollment prediction.

Abstract: Contact of endothelial cells with inhibitors of inhibin and/or the alpha-subunit of inhibin can be utilized to modify the activity of endothelial cell expression products including SMAD1/5. Methods can also include inhibiting ALK1 and/or endoglin as components of inhibin-activated pathway of SMAD1/5 signaling. Methods can be combined with other anti-angiogenesis therapies such as anti-VEGF therapies. Methods can be utilized in treatment of inhibin-expressing cancers (e.g., ovarian cancer, pancreatic cancer) as well as other pathologies such as pre-eclampsia and PCOS.

Abstract: There is a need for improving data security in enrollment management systems. This need can be addressed by, for example, solutions for determining an enrollment recommendation for a primary member profile based on preconfigured enrollment modeling data. In one example, a method includes retrieving enrollment modeling data for a group of member profiles, determining a plurality of related member profiles for the primary member profile from the group of member profiles, determining a cross-member enrollment prediction for the primary member profile by comparing enrollment modeling data of the primary member profile and enrollment modeling data of each related member profile, determining a member-specific enrollment recommendation by comparing enrollment modeling data of the primary member profile and enrollment coverage criteria for each enrollment plan, and determining the enrollment recommendation based on the cross-member enrollment prediction and the member-specific enrollment prediction.

Abstract: A method, system, and non-transitory computer-readable storage medium for temporal information synchronization of imaging devices are disclosed. The method comprises capturing media using an imaging device, generating a sequence identifier for each of the media, generating a timestamp for each of the media, determining that at least one of the media includes an unknown time tag, receiving an input including temporal information, determining a time offset between each timestamp and the temporal information, and updating the timestamp for each of the media that includes an unknown time tag using the time offset to provide an updated timestamp.

Abstract: Contact of endothelial cells with inhibitors of inhibin and/or the alpha subunit of inhibin can be utilized to modify the activity of endothelial cell expression products including SMAD 1/5. Methods can also include inhibiting Alk1 and/or endoglin as components of inhibin-activated pathway of SMAD 1/5 signaling. Methods can be combined with other anti-angiogenesis therapies such as anti-VEGF therapies. Methods can be utilized in treatment of inhibin-expressing cancers (e.g., ovarian cancer, pancreatic cancer) as well as other pathologies such as preeclampsia and PCOS.

Abstract: Described herein are microbial stimulating compounds that act as a surfactant to increase fermentation. Also described are methods for enhancing fermentation utilizing these compounds as well as methods for the producing the compounds from lignocellulosic biomass and biomass components during high temperature reactions with alcohols. The stimulating compounds can be produced from a variety of polysaccharides or sugars.

Abstract: A method, system, and non-transitory computer-readable storage medium for temporal information synchronization of imaging devices are disclosed. The method comprises capturing media using an imaging device, generating a sequence identifier for each of the media, generating a timestamp for each of the media, determining that at least one of the media includes an unknown time tag, receiving an input including temporal information, determining a time offset between each timestamp and the temporal information, and updating the timestamp for each of the media that includes an unknown time tag using the time offset to provide an updated timestamp.

Abstract: There is a need for improving data security in enrollment management systems. This need can be addressed by, for example, solutions for determining an enrollment recommendation for a primary member profile based on preconfigured enrollment modeling data. In one example, a method includes retrieving enrollment modeling data for a group of member profiles, determining a plurality of related member profiles for the primary member profile from the group of member profiles, determining a cross-member enrollment prediction for the primary member profile by comparing enrollment modeling data of the primary member profile and enrollment modeling data of each related member profile, determining a member-specific enrollment recommendation by comparing enrollment modeling data of the primary member profile and enrollment coverage criteria for each enrollment plan, and determining the enrollment recommendation based on the cross-member enrollment prediction and the member-specific enrollment prediction.

Abstract: A method, system, and non-transitory computer-readable storage medium for temporal information synchronization of imaging devices are disclosed. The method comprises capturing media using an imaging device, generating a sequence identifier for each of the media, generating a timestamp for each of the media, determining that at least one of the media includes an unknown time tag, receiving an input including temporal information, determining a time offset between each timestamp and the temporal information, and updating the timestamp for each of the media that includes an unknown time tag using the time offset to provide an updated timestamp.

Abstract: An image sensor may generate visual output signals conveying visual information. The visual information may define visual content based on light received within a field of view of the image sensor. A sound sensor may receive and convert sounds into sound output signals. A voice command to operate in a sharing mode may be detected based on the sound output signals. Operation in the sharing mode may cause visual content captured by the image sensor during operation in the sharing mode to be accessible to members of a sharing group. Operation outside the sharing mode may case visual content captured by the image sensor during operation outside the sharing mode to not be accessible to the members of the sharing group. The visual information defining the visual content captured by the image sensor during the operation in the sharing mode may be stored in shared storage media.

Abstract: Contact of endothelial cells with inhibitors of inhibin and/or the alpha subunit of inhibin can be utilized to modify the activity of endothelial cell expression products including SMAD 1/5. Methods can also include inhibiting Alk1 and/or endoglin as components of inhibin-activated pathway of SMAD 1/5 signaling. Methods can be combined with other anti-angiogenesis therapies such as anti-VEGF therapies. Methods can be utilized in treatment of inhibin-expressing cancers (e.g., ovarian cancer, pancreatic cancer) as well as other pathologies such as preeclampsia and PCOS.